Dana Šimková

479 total citations
7 papers, 378 citations indexed

About

Dana Šimková is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Dana Šimková has authored 7 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Dana Šimková's work include Cancer-related gene regulation (3 papers), PARP inhibition in cancer therapy (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). Dana Šimková is often cited by papers focused on Cancer-related gene regulation (3 papers), PARP inhibition in cancer therapy (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). Dana Šimková collaborates with scholars based in Czechia, United Kingdom and Denmark. Dana Šimková's co-authors include Jan Bouchal, Gvantsa Kharaishvili, Mariam Gachechiladze, Kateřina Bouchalová, Gabriela Kořínková, Martin Mistrík, Jiřina Bártková, Jiří Bártek, Kamila Wolanin and Alan Lau and has published in prestigious journals such as Blood, Oncotarget and Cell Cycle.

In The Last Decade

Dana Šimková

7 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Šimková Czechia 6 224 218 70 47 47 7 378
Magdalena Zietarska Canada 6 208 0.9× 185 0.8× 85 1.2× 27 0.6× 72 1.5× 6 459
Yumi Kinugasa Japan 9 273 1.2× 254 1.2× 65 0.9× 56 1.2× 106 2.3× 10 472
Sarah B. Crist United States 7 298 1.3× 235 1.1× 85 1.2× 27 0.6× 108 2.3× 10 452
Rachel A. Davidowitz United States 5 190 0.8× 209 1.0× 92 1.3× 37 0.8× 70 1.5× 6 439
Paula Deschamps Canada 11 327 1.5× 113 0.5× 36 0.5× 56 1.2× 63 1.3× 16 468
Majdi Maiel France 2 189 0.8× 226 1.0× 66 0.9× 34 0.7× 89 1.9× 2 372
Garima Kaushik United States 7 221 1.0× 176 0.8× 35 0.5× 49 1.0× 114 2.4× 12 409
Ming-Qing Gao South Korea 8 220 1.0× 238 1.1× 89 1.3× 31 0.7× 129 2.7× 9 448
Candice Alexandra Grzelak United States 8 193 0.9× 199 0.9× 53 0.8× 31 0.7× 133 2.8× 10 420
Valentina Poltavets Australia 4 148 0.7× 202 0.9× 76 1.1× 27 0.6× 86 1.8× 6 375

Countries citing papers authored by Dana Šimková

Since Specialization
Citations

This map shows the geographic impact of Dana Šimková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Šimková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Šimková more than expected).

Fields of papers citing papers by Dana Šimková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Šimková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Šimková. The network helps show where Dana Šimková may publish in the future.

Co-authorship network of co-authors of Dana Šimková

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Šimková. A scholar is included among the top collaborators of Dana Šimková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Šimková. Dana Šimková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Majera, Dušana, Zdeněk Škrott, Jan Bouchal, et al.. (2018). Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. The Prostate. 79(4). 352–362. 24 indexed citations
2.
Šimková, Dana, Gvantsa Kharaishvili, Eva Slabáková, Philip I. Murray, & Jan Bouchal. (2016). Glycoprotein asporin as a novel player in tumour microenvironment and cancer progression. Biomedical Papers. 160(4). 467–473. 14 indexed citations
3.
Šimková, Dana, Gvantsa Kharaishvili, Gabriela Kořínková, et al.. (2016). The dual role of asporin in breast cancer progression. Oncotarget. 7(32). 52045–52060. 28 indexed citations
5.
Kharaishvili, Gvantsa, et al.. (2014). The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell International. 14(1). 41–41. 152 indexed citations
6.
Wolanin, Kamila, Martin Mistrík, Gabriela Kořínková, et al.. (2012). Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment. Cell Cycle. 11(20). 3837–3850. 126 indexed citations
7.
Kharaishvili, Gvantsa, et al.. (2011). WNT SIGNALING IN PROSTATE DEVELOPMENT AND CARCINOGENESIS. Biomedical Papers. 155(1). 11–18. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026